The Canadian orphan drug market – Eric Gervais of Medunik Canada

In Orphan Drug Congress by Tim Peplow

Eric Gervais, Executive Vice President of Medunik Canada, presented at World Orphan Drug Congress USA 2013 on the topic, ‘Myth and reality on the Canadian orphan market.’

Key areas of discussion include:

• Earning revenues prior to Health Canada approval
• Establishing your price in Canada — Patented Medicine Prices Review Board (PMPRB)
• Targeting products eligible for reimbursement

World Orphan Drug Congress USA is the largest international, commercially-focused event for the advancement of rare disease research and orphan drug development. Find more information on the 2014 here.